Feasibility Study of a Novel Single Use Robotic Colonoscopy System

Inclusion Criteria: * Males aged between 40 and 70 years, inclusive, at the time of informed consent * Females aged between 55 and 70 years, inclusive, at the time of informed consent (Rationale: to include only women with non-childbearing potential to avoid completely pregnant trial subjects) * Symptomatic adults indicated for elective colonoscopy, or asymptomatic adults willing to undergo a colonoscopic screening for polyps or colorectal cancer * Adults without prior colonoscopy * Able to provide a written informed consent form approved by an Independent Ethics Committee (IEC)/ Institutional Review Board (IRB), prior to any study-specific procedures * Willing and able to comply with the study procedures Exclusion Criteria: * History of colorectal cancer, inflammatory bowel disease, polyposis syndrome, familial polyposis coli, hereditary nonpolyposis colorectal cancer syndrome, active diverticulitis or toxic megacolon * Lower gastrointestinal bleeding within 28 days prior to the colonoscopy day * Known bleeding tendency * Received antiplatelet or anticoagulation therapy within 3 days prior to the colonoscopy day * Known colonic stricture * Known multiple sigmoid colon diverticula * History of any abdominal or pelvis surgical procedures including colonic and rectal surgical resection * Known abdominal wall hernias * History of radiotherapy to the abdomen or pelvis * Known coronary ischemia or cardiovascular stroke within 3 months prior to the colonoscopy day * Contraindication to the proposed anaesthesia * Received any investigational medicine or treatment within 28 days prior to Screening * Any condition, in the opinion of the Investigator, that is unstable and could jeopardize the safety of the subject and their compliance in the study